Single- versus dual-infusion of B-cell-depleting antibody ocrelizumab in rheumatoid arthritis: results from the Phase III FEATURE trial von Huffstutter, Joseph E, Taylor, James, Schechtman, Joy, Leszczynski, Piotr, Brzosko, Marek, Sedarati, Farhad, Moawad, Dalia, Kapp, Amy V, Sudlow, Rebecca, Dummer, Wolfgang

Volltext

Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study von Huffstutter, Joseph E., Kafka, Shelly, Brent, Lawrence H., Matucci-Cerinic, Marco, Kezhen L. Tang, Chevrier, Marc, Trev Sprabery, DeHoratius, Raphael J.

Volltext bestellen

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates von Dore, Robin K, Cohen, Stanley B, Lane, Nancy E, Palmer, William, Shergy, William, Zhou, Lifen, Wang, Huei, Tsuji, Wayne, Newmark, Richard

Volltext

Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative von Khanna, D, Tan, Ma, Furst, D E, Hill, N S, McLaughlin, V V, Silver, R M, Steen, V D, Langer, A, Seibold, J R

Volltext

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐co... von Cohen, Stanley B., Dore, Robin K., Lane, Nancy E., Ory, Peter A., Peterfy, Charles G., Sharp, John T., van der Heijde, Désirée, Zhou, Lifen, Tsuji, Wayne, Newmark, Richard

Volltext